Menu
ncarol.com
  • Home
  • Books
  • Book Release
  • Health
  • Business
  • Financial
  • Arts
  • Non-profit
  • Real Estate
ncarol.com

Lineus Medical and New England Medical Specialties Announce Partnership NEMS to Distribute SafeBreak® Vascular in New England
ncarol.com/10150542

Trending...
  • NextBoat's AI-Powered Marine Marketplace Gains Momentum as Record Growth Signals an Inflection Point for Investors (N Y S E American: NXB)
  • Allstream Energy Partners Returns as a Media Partner for the 2026 API Inspection & Mechanical Integrity Summit in San Antonio
  • Heritage at Manalapan Introduces Luxury Single-Family Homes with Exceptional Value in One of Monmouth County's Most Desirable Locations
New England Med Spec Logo SafeBreak Vascular SafeBreak On Patient Lineus Medical
FAYETTEVILLE, Ark. - ncarol.com -- Lineus Medical, after receiving FDA clearance in May 2021 for its flagship product – SafeBreak Vascular, continues to expand its distribution network into the Northeast with the signing of New England Medical Specialties. NEMS specialize in products for I.V. Therapy, vascular access, oncology, and fall prevention. Their sales team covers Vermont, New Hampshire, Massachusetts, Rhode Island, Connecticut, and New York on behalf of Lineus Medical.

"New England Medical Specialties has provided innovative medical device solutions to our customers for over 35 years." said NEMS President Bob Proietto. "We specialize in I.V. therapy and vascular access and know that SafeBreak Vascular is going to be an important part of our product portfolio. SafeBreak Vascular is an innovative product, and we are known for bringing new technologies to the marketplace."

Lineus Medical CEO, Vance Clement, added, "When partnering with medical device distributors, we work with the best. New England Medical Specialties is the leader in their area of the country, and we are thrilled to have them represent us. Our flagship product, SafeBreak Vascular, was proven to reduce IV complications requiring an IV restart by 44% in a randomized clinical study in Hartford, CT1. Having a study conducted in New England is an impactful starting point for Bob Proietto and his team."

More on ncarol.com
  • New Novel WINCE Takes Unflinching Aim at American Gun Culture and Masculinity
  • New Research Puts the Cost of Enterprise Decision Delay at $630 Billion a Year Across the Global 2000
  • Cover Story about Matthew Cossolotto – Author of Harness Your PromisePower -- Published in July 2026 Enterprise World Magazine
  • Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy
  • New Research: Deterministic Decompilation of Hermes Bytecode Back to Readable JavaScript

SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer lock in the world. The device is designed to separate when damaging force is placed on an IV line, reducing vein irritation and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient.

SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Peripheral IVs fail 46% of the time before their intended use is complete according to the clinical literature and cost the US healthcare system over $5B annually2.

ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other  medical tubing may be reduced when a force-activated separation device is used. Learn more at www.lineusmed.com and follow us on LinkedIn or Twitter.

More on ncarol.com
  • Lionheart Holdings and KEO Energy Sign Letter of Intent for Proposed Business Combination
  • First Flight Society Celebrates National Aviation Day 2026 on Wednesday, August 19th
  • Marcus Christ Announces Singles: "The Hammer Goes Click" and "You Hate Me, I Hate You"
  • Nina Simone and Samuel Waymon Music Scholarship Fund Opens 2026/27 Application Cycle
  • Fatal FOMO May be Your Last Roll of the Dice

1D.I.P.P.E.R Study - Data on file.
2Data on file.
3Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015;38(3): 189-203

MKG-0122 Rev 0

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Bynn Intelligence Ranks #1 in NIST Child Online Safety Evaluation for Ages 13–16
  • Rev-O-Box™ Launches Reversible Shipping Box That Instantly Becomes a Premium Gift Box
  • Las Vegas Estate Firm Ghandi Deeter Blackham Offers Insight on Tony Hsieh's Contested $500 Million Will
  • Ms. Marie's Coffee Blend Launches Local Delivery Service Beginning in Lexington, North Carolina
  • CCHR: Congressional Hearing Revives Lessons from MKULTRA Era – Why Past Psychiatric Human Rights Abuses Demand Vigilance Today
  • Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe
  • Heritage at Manalapan Introduces Luxury Single-Family Homes with Exceptional Value in One of Monmouth County's Most Desirable Locations
  • Achugogo: Tale of the Spring Chaser Wins Inaugural TCCF Prize at Mifa Pitches, the Industry Market of the Annecy International Animation Film Festival
  • Everything Policy Launches Madison, an AI Tool That Makes Legislation Readable for Students and Citizens
  • TOLI North America Implements Modest Price Increase, Absorbing Majority of Costs
  • Is the Market Missing One of the Most Undervalued Cybersecurity Companies on the Stock Market? Cycurion, Inc. (N A S D A Q: CYCU):
  • Billion-Dollar Scale Global Technology Powerhouse Being Built with Expanding Government Contracts: Circle8 Group (N A S D A Q: CIRC)
  • Nevada Boxing Hall of Fame Gears Up for Star-Studded 14th Annual Induction Gala Weekend
  • New Thriller 'Counterframe' Explores the Hidden Vulnerabilities of Modern Society
  • Award-Winning Heritage at South Brunswick Continues to Thrive as One of New Jersey's Premier New Home Communities
  • Four Seasons Cleaners Debuts Santa Barbara County's First 24/7 Dry Cleaning Kiosk New self-service
  • WhereTu Launches to Help Americans Build Successful Lives Abroad
  • BoatRegistrationNumbers.com Launches Next-Generation Marine Lettering, Decals and Numbers Tool
  • Appliance EMT Expands Built-In and Walk-In Refrigerator Service in Metro Atlanta
  • New from Regal House Publishing, Call it Madness: a missing grandfather - reclaiming a ruptured life
_catLbl0 _catLbl1

Popular on ncarol.com

  • RAS AP Consulting Expands AP Governance & Automation Practice and Named Finalist for Heidelberg Materials SAP Vendor & Customer Data Project - 135
  • Sexually Abused in a Psychiatric Hospital or Psychiatrist's or Psychologist's Office? CCHR Urges Survivors to Reach Out to It - 124
  • Healthcare Leaders Publish New Integrated Behavioral Healthcare Guide, Led by Doctors of Behavioral Health - 102
  • Nayarit Strengthens Its Position as a Global Surf Destination; Sayulita to Become Mexico's First Official Surf City - 102
  • Wagga Trucks set to expand to the Canberra Region as authorised dealer for Volvo, UD & Mack along with Freighter Group Trailers
  • UK Financial Ltd. Opens Test-Phase Maya 3 Liquidity Pool on Uniswap with DEX Screener Visibility for Market-Smoothing Ahead of CATEX Exchange Launch
  • BumblebeeSmart Announces Partnership with Extreme Kids World to Expand Access to Sensory Wall Panels and Educational Busy Boards
  • OneVizion Names AI Leader Matthew Kirk as Chief Operating Officer to Drive Governed AI Across Telecom and Electric Utilities
  • Director Sean McNamara Reunites with Award-Winning Cinematographer Shawn Seifert for Upcoming Feature Home
  • Triple-Digit Growth, Stock Market Upgrade plus a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation (Stock Symbol: CDIX)

Similar on ncarol.com

  • U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections
  • Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy
  • Missouri Hemp Businesses File Federal Lawsuit Challenging HB 2641
  • SUN Automation Group and KOLBUS America Align Hycorr Parts Support to Enhance Customer Service
  • Boston Industrial Solutions Launches New Citrine® SA1-370 Silicone Glue for Permanent Adhesion
  • Bynn Intelligence Ranks #1 in NIST Child Online Safety Evaluation for Ages 13–16
  • CCHR: Congressional Hearing Revives Lessons from MKULTRA Era – Why Past Psychiatric Human Rights Abuses Demand Vigilance Today
  • Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe
  • TOLI North America Implements Modest Price Increase, Absorbing Majority of Costs
  • Studica Robotics Supports Robotics Training Camp for WorldSkills Shanghai 2026
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute